论文信息 - Phase 1 study of combinatorial sorafenib, G‐CSF, and plerixafor treatment in relapsed/refractory, FLT3‐ITD‐mutated acute myelogenous leukemia patients - 字舞流文

Phase 1 study of combinatorial sorafenib, G‐CSF, and plerixafor treatment in relapsed/refractory, FLT3‐ITD‐mutated acute myelogenous leukemia patients

M. Konopleva | M. Andreeff | H. Kantarjian | J. Cortes | Xuelin Huang | K. Patel | T. Kadia | F. Ravandi | G. Borthakur | N. Daver | T. McQueen | Z. Zeng | Hsiang-Chun Chen | M. Kelly | R-Y Wang